The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium

Piet Vanhaesebrouck1, Karel Allegaert, Jean Bottu

  • 1Department of Neonatology, University Hospital Ghent, De Pintelaan 185 B-9000 Ghent, Belgium. piet.vanhaesebrouck@ugent.be

Pediatrics
|September 3, 2004
PubMed

Insights

Outcomes for extremely preterm infants born at <=26 weeks gestation are poor. Survival to discharge was 54%, with <15% of survivors free from serious neonatal morbidity.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Pediatric Critical Care

Background:

  • Extremely preterm infants born at <=26 weeks gestation represent a vulnerable population with significant mortality and morbidity risks.
  • Understanding discharge outcomes is crucial for parental counseling and clinical decision-making.

Purpose of the Study:

  • To determine the mortality and morbidity at hospital discharge for a large population-based cohort of infants born at <=26 weeks gestation.
  • To identify factors associated with adverse outcomes in this population.

Main Methods:

  • A population-based cohort study was conducted in 19 Belgian perinatal centers.
  • Perinatal data were collected for infants alive at the onset of labor between January 1, 1999, and December 31, 2000.
  • Survival and major adverse outcomes at discharge were analyzed.

Main Results:

  • The overall survival rate for liveborn infants was 54%, with 82% of those alive at 7 days surviving to discharge.
  • Factors independently associated with death included vaginal delivery, shorter gestation, air leak, prolonged ventilator dependence, and higher initial oxygen requirement.
  • Among survivors, 63% had at least one major adverse outcome (neuromorbidity, chronic lung disease, or retinopathy of prematurity).
  • Survival free from serious neonatal morbidity at discharge was less than 15% for infants with gestation <26 weeks.

Conclusions:

  • For infants born at <26 weeks gestation, outcome perspectives and treatment options, including nonintervention, should be discussed with parents.
  • Discussions should occur within the limits of medical feasibility and appropriateness when pregnancy prolongation is unsuccessful.
Abstract

Related Concept Videos